Anticancer agent that is clinically used to treat nonlymphocytic leukemia. Inhibits RNA and DNA synthesis and causes DNA fragmentation in vivo
. Reduces tau mRNA levels in vitro
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
Aubel-Sadron and Londos-Gagliardi
Signaling pathways activated by daunorubicin.
Laurent and Jaffrezou
Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression.
Dickey et al.
The citations listed below are publications that use Tocris products. Selected citations for Daunorubicin hydrochloride include:
Showing Results 1 - 1 of 1